Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.
As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. With the arrival of NVIDIA's GeForce RTX 50 Series ...
During a recent appearance on the “So True with Caleb Hearon” podcast, co-director Lilly Wachowski was asked about certain right-wing groups attaching their ideologies to her 1999 sci-fi masterpiece ...
Laurence Fishburne has addressed whether he might step back into the role of Morpheus for The Matrix 5. Appearing at New York Comic Con 2025 for The Matrix reunion panel, the actor said that he is ...
A second look at the sequel that split the fandom. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. But here’s the thing: I recently rewatched ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...
A new casting rumor has revealed whether Keanu Reeves’ Neo will return in Warner Bros.’ upcoming The Matrix 5. Known for his role as the prophesied One who disrupted the machines’ simulated reality, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In addition to news coming out ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: Warner Bros. A new casting rumor has revealed whether Keanu Reeves’ Neo will return in Warner Bros.’ upcoming The ...
As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge. Founded in 2021 as a spinoff of Alphabet AI company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results